Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Fu, Da  [Clear All Filters]
2014
Qin R, Zhou J, Chen C, Xu T, Yan Y, Ma Y, Zheng Z, Shen Y, Lu Y, Fu D, et al. LIN28 Is Involved in Glioma Carcinogenesis and Predicts Outcomes of Glioblastoma Multiforme Patients. PLoS One. 2014;9(1):e86446.
2016
Sun X, Zhang H, Luo L, Zhong K, Ma Y, Fan L, Fu D, Wan L. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma. Oncol Rep. 2016.
2019
Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L, Qian M, Guo J, Xu J, Cao L, et al. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell. 2019:e13027.
2021
Ma Y-S, Yang X-L, Liu Y-S, Jiang X-H, Ding H, Shi Y, Ji C-Y, Lu G-X, Zhang D-D, Wang H-M, et al. microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway. Cell Signal. 2021:110025.
Ma Y-S, Yang X-L, Xin R, Wu T-M, Shi Y, Zhang DDan, Wang H-M, Wang P-Y, Bin Liu J-, Fu D. The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation. Transl Oncol. 2021;14(8):101126.
2023
Zhai S, Lin J, Ji Y, Zhang R, Zhang Z, Cao Y, Liu Y, Tang X, Liu J, Liu P, et al. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer. Cell Discov. 2023;9(1):95.